METTL3 and breast carcinoma: METTL3 protein and mRNA levels were found to be significantly increased, as shown in Figure 2a–d, from Western blotting and quantitative real-time PCR (qRT-PCR), while the opposite results were observed for the loss of ADAR1 expression in breast cancer cell lines (Figure 2e–h).